The Determinants of AIDS Mortality: Evidence from a State-Level Panel
This paper relies on a panel of state-level data to address the socio-economic determinants of AIDS mortality in the United States. We find that male and female AIDS mortality rates are dependent on a number of factors, including per capita income, physician supply, per capita prescription drug expenditure, and race. The role of prescription drug expenditure is found to be sensitive to its level of aggregation, with the absolute value of the prescription drug expenditure elasticity lower when AIDS drug assistance program (ADAP) expenditures are utilized. Also, for the ADAP expenditure regressions, the prescription drug expenditure elasticity is highest in absolute value for males. Copyright International Atlantic Economic Society 2009
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Volume (Year): 37 (2009)
Issue (Month): 4 (December)
|Contact details of provider:|| Postal: Suite 650, International Tower, 229 Peachtree Street, N.E., Atlanta, GA 30303|
Phone: (404) 965-1555
Fax: (404) 965-1556
Web page: http://springerlink.metapress.com/link.asp?id=112055
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Farasat A.S. Bokhari & Yunwei Gai & Pablo Gottret, 2005.
"Government Health Expenditures and Health Outcomes,"
wp2005_02_01, Department of Economics, Florida State University, revised May 2006.
- Farasat A. S. Bokhari & Yunwei Gai & Pablo Gottret, 2007. "Government health expenditures and health outcomes," Health Economics, John Wiley & Sons, Ltd., vol. 16(3), pages 257-273.
- Michael P. Murray, 2006. "Avoiding Invalid Instruments and Coping with Weak Instruments," Journal of Economic Perspectives, American Economic Association, vol. 20(4), pages 111-132, Fall.
- Pierre-Yves Crémieux & Pierre Ouellette & Caroline Pilon, 1999. "Health care spending as determinants of health outcomes," Health Economics, John Wiley & Sons, Ltd., vol. 8(7), pages 627-639.
- Hitiris, Theo & Posnett, John, 1992. "The determinants and effects of health expenditure in developed countries," Journal of Health Economics, Elsevier, vol. 11(2), pages 173-181, August.
- Ettner, Susan L., 1996. "New evidence on the relationship between income and health," Journal of Health Economics, Elsevier, vol. 15(1), pages 67-85, February.
- Pierre-Yves Crémieux & Marie-Claude Meilleur & Pierre Ouellette & Patrick Petit & Martin Zelder & Ken Potvin, 2005. "Public and private pharmaceutical spending as determinants of health outcomes in Canada," Health Economics, John Wiley & Sons, Ltd., vol. 14(2), pages 107-116.
- Macintyre, Sally & Hunt, Kate & Sweeting, Helen, 1996. "Gender differences in health: Are things really as simple as they seem?," Social Science & Medicine, Elsevier, vol. 42(4), pages 617-624, February.
When requesting a correction, please mention this item's handle: RePEc:kap:atlecj:v:37:y:2009:i:4:p:425-436. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Sonal Shukla)or (Rebekah McClure)
If references are entirely missing, you can add them using this form.